In liver cancer, IGFBP7 induces anti-tumor effects by binding to the IGF1 receptor (IGF1R) to inhibit IGF signaling [25]; in colon cancer, IGFBP7 down-regulates EMT to promote liver metastasis [26]. Here, IGF1R is linked to malignant colon neoplasm.